Search clinical trials for: 1% OPA-15406 Ointment
Total 150 results
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Otsuka Beijing Research InstituteRecruiting
-
Otsuka Pharmaceutical Co., Ltd.CompletedAtopic DermatitisJapan
-
Otsuka Beijing Research InstituteRecruitingAtopic Dermatitis (AD)China
-
Medimetriks Pharmaceuticals, IncCompletedAtopic DermatitisUnited States, Honduras, Panama
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAtopic DermatitisPoland, United States, Australia
-
Otsuka Pharmaceutical Co., Ltd.CompletedAtopic DermatitisJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedAtopic DermatitisJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedAtopic DermatitisJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
PharmaEssentiaPharmaEssentia Japan K.K.Completed
-
PfizerCompletedDermatitis, AtopicAustralia
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAtopic DermatitisUnited States
-
Hovione Scientia LimitedCompletedMeibomian Gland Dysfunction | MGD-Meibomian Gland DysfunctionUnited States
-
PharmaEssentiaPharmaEssentia Japan K.K.Completed
-
Ziarco Pharma LtdCompletedAtopic DermatitisUnited Kingdom
-
GlaxoSmithKlineCompletedSkin Infections, BacterialUnited States, South Africa, India, Argentina, Brazil
-
Technoderma Medicines Inc.Therapeutics, Inc.Not yet recruiting
-
GlaxoSmithKlineCompletedSkin Infections, BacterialNetherlands, Costa Rica, Germany, Mexico, Canada, India, Poland, South Africa, France, Peru
-
Oneness Biotech Co., Ltd.Completed
-
GlaxoSmithKlineCompletedSkin Infections, BacterialUnited States, Germany, Taiwan, Netherlands, Argentina, Chile, Costa Rica, South Africa, Mexico
-
GlaxoSmithKlineCompletedImpetigoIndia, Mexico, Netherlands, Italy, Peru
-
Austin Institute for Clinical ResearchRecruitingSuperficial Basal Cell CarcinomaUnited States
-
DermaGen ABCompleted
-
Circassia LimitedBioskin GmbHCompletedPsoriasis VulgarisGermany
-
Dong-A University HospitalCompletedColorectal Cancer | Pancreatic Cancer | Non-small Cell Lung CancerKorea, Republic of
-
HK inno.N CorporationNot yet recruiting
-
Castle Creek Pharmaceuticals, LLCTerminatedEpidermolysis Bullosa SimplexUnited States, Israel, Australia, Austria, France, Germany, Netherlands, United Kingdom
-
National Institute of Mental Health (NIMH)Completed
-
Valo Health, Inc.Withdrawn
-
Novartis PharmaceuticalsCompletedErythemato-telangiectatic RosaceaUnited States
-
University of ArizonaCompletedTraumatic Brain Injury (TBI) | Chronic Traumatic Encephalopathy (CTE)United States
-
Hospital Universitari Vall d'Hebron Research InstituteUnknown
-
Emory UniversityGeorgia Center for Oncology Research & EducationNot yet recruitingHuman Immunodeficiency Virus | Human Papilloma Virus | Anal Intraepithelial Neoplasia | High-Grade Squamous Intraepithelial LesionsUnited States
-
Valo Health, Inc.RecruitingProliferative Diabetic Retinopathy | Non-proliferative Diabetic RetinopathyUnited States
-
University of OklahomaNot yet recruitingForehead; Wound
-
Technical University of DenmarkDanish Dementia Research CentreCompletedHearing Loss | Cognitive Impairment, MildDenmark
-
Castle Creek Pharmaceuticals, LLCCompletedDystrophic Epidermolysis Bullosa | Epidermolysis Bullosa Simplex | Junctional Epidermolysis Bullosa | Epidermolysis Bullosa (EB)United States
-
Castle Creek Pharmaceuticals, LLCTKL Research, Inc.Completed
-
Castle Creek Pharmaceuticals, LLCCompleted
-
Castle Creek Pharmaceuticals, LLCCompleted
-
Beijing Tiantan HospitalCompletedElectroencephalographyChina
-
Castle Creek Pharmaceuticals, LLCCompleted
-
Ferrer Internacional S.A.CompletedEfficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With ImpetigoImpetigoGermany, South Africa
-
TWi Biotechnology, Inc.TerminatedBullous PemphigoidTaiwan
-
Castle Creek Pharmaceuticals, LLCCompletedEpidermolysis Bullosa | Epidermolysis Bullosa SimplexUnited States
-
Sohag UniversityUnknownVitiligo | TacrolimusEgypt
-
Almirall, S.A.CompletedKeratosis, ActinicUnited States